Rocket One Inc. Financing Receivable Accrued Interest Modified
Rocket One Inc. (RKTO) reported Financing Receivable Accrued Interest Modified of $6.00 thousand for the 0-month period ending 2022-10-21, per its 10-K filed 2024-03-28.
Discontinued › Notes › Receivables › and Others
us-gaap:FinancingReceivableAccruedInterestModified · last filed 2024-03-28
- 2022-10-21: Financing Receivable Accrued Interest Modified 0 month $6.00K.
| Period end | Financing Receivable Accrued Interest Modified 0 month |
|---|---|
| 2022-10-21 | $6.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |